WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Stock Ownership - Who owns Theravance Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Theravance Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eli Samaha10% Owner2026-07-075,564$17.17
$95.54kSell
Eli Samaha10% Owner2026-07-061,400$17.04
$23.86kSell
Eli Samaha10% Owner2026-07-0137,799$17.00
$642.62kSell
Eli Samaha10% Owner2026-06-3025,027$17.13
$428.79kSell
Eli Samaha10% Owner2026-06-29273,871$17.24
$4.72MSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2026-06-153,328$16.38
$54.53kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2026-06-156,657$16.39
$109.08kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2026-06-153,329$16.39
$54.56kSell
Rick E. WinninghamCHIEF EXECUTIVE OFFICER2026-05-2020,038$16.55
$331.63kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2026-05-205,678$16.55
$93.97kSell

1 of 4

TBPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TBPH insiders and whales buy or sell their stock.

TBPH Shareholders

What type of owners hold Theravance Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eli Samaha34.05%17,678,839$299.66MInsider
Glaxosmithkline PLC18.58%9,644,807$163.48MInsider
Weiss Asset Management LP14.36%7,457,060$126.40MInsider
Rick E. Winningham3.36%1,747,023$29.61MInsider
Frank Pasqualone0.83%429,783$7.28MInsider
Andrew A. Hindman0.74%384,714$6.52MInsider
Kenneth R. Pitzer0.73%380,123$6.44MInsider
Brett A. Grimaud0.70%363,120$6.15MInsider
Aziz Sawaf0.66%344,953$5.85MInsider
Philip D. Worboys0.64%330,752$5.61MInsider

1 of 3

TBPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TBPH0.09%82.21%Net SellingNet Selling
ANL0.01%9.12%Net Selling
SGP0.03%99.97%Net Buying
OCS0.03%0.00%
FDMT0.11%22.63%Net SellingNet Selling
View Top Biotech Stocks

Theravance Biopharma Stock Ownership FAQ

Who owns Theravance Biopharma?

Theravance Biopharma (NASDAQ: TBPH) is owned by 0.09% institutional shareholders, 82.21% Theravance Biopharma insiders, and 17.69% retail investors. Eli Samaha is the largest individual Theravance Biopharma shareholder, owning 17.68M shares representing 34.05% of the company. Eli Samaha's Theravance Biopharma shares are currently valued at $300.72M.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.